Kliniska studier för Melanom i Arizona
26 studier för Melanom söker deltagare vid platser i Arizona.
Städer i Arizona
Officiell studietext (engelska)
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- HonorHealth Research Institute, Scottsdale
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07751042Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Mayo Clinic Hospital in Arizona, Phoenix
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Ironwood Cancer & Research Centers, Chandler
- Banner MD Anderson Cancer Center, Gilbert
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06246916Pan-tumor MRD Study
- Mohtaseb Cancer Center and Blood Disorders, Bullhead City
- Cancer & Blood Specialists of Arizona, Casa Grande
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Cancer Center at Saint Joseph's, Phoenix
RekryterarFas 3
Ålder 75 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07068074Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
RekryterarFas 1/2
Ålder 18 till 99 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06814496ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT05059444DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
- Banner MD Anderson Cancer Center, Gilbert
- Arizona State University-Honor Health Research Institute, Scottsdale
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07288112Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Arizona, Tucson
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07287917A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Mayo Clinic Arizona, Phoenix
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT07070232Project: Every Child for Younger Patients With Cancer
- Kingman Regional Medical Center, Kingman
- Banner Children's at Desert, Mesa
- Phoenix Childrens Hospital, Phoenix
- och 1 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
- HonorHealth Research Institute, Scottsdale
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 aug. 2026 · NCT06425926Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Mayo Clinic Scottsdale - PPDS, Scottsdale
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 6 maj 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- HonorHealth Research Insisute, Scottsdale
RekryterarFas 2/3
Alla åldrar · Alla kön · Uppdaterad 2 apr. 2026 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Mayo Clinic Arizona, Phoenix
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 feb. 2026 · NCT05549297Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Mayo Clinic Hospital, Phoenix
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 dec. 2025 · NCT03567889A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 21 nov. 2025 · NCT05914116Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- HonorHealth Research and Innovation Institute, Scottsdale
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 29 okt. 2025 · NCT06249048SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Phoenix, Phoenix
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 27 nov. 2024 · NCT03860883A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Arizona, Scottsdale
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 nov. 2024 · NCT05824975Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- HonorHealth Research Institute, Scottsdale
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 nov. 2024 · NCT04787042Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- HonorHealth Research Institute, Scottsdale
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 8 feb. 2024 · NCT04282044Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.